Results 1 to 10 of about 16,495 (210)

Anticardiolipin antibodies in patients with Behcet's disease [PDF]

Biomolecules & Biomedicine, 2011
The aims of this study are to determine anticardiolipin antibodies in patients with Sy Behcet and to determine correlation between the levels of anticardiolipin antibodies in serum in patients with clinic systemic and ocular manifestations.
Maja Zivkovic, Marko Zlatanovic, Gordana Zlatanovic, Jasmina Djordjevic-Jocic, Sonja Cekic   +4 more
doaj   +2 more sources

Prevalence of antiphospholipid syndrome among women with recurrent pregnancy loss: a cohort study [PDF]

Revista Brasileira de Ginecologia e Obstetrícia
Objective: This study aimed to evaluate the prevalence of antiphospholipid syndrome (APS) among women experiencing recurrent pregnancy loss (RPL). Methods: A cross-sectional was conducted, reviewing the medical records of 134 women with a history of two
Elaine Cristina Fontes de Oliveira, Daniel Dias Ribeiro, Janaína Campos Senra, Fernando Marcos dos Reis   +3 more
doaj   +2 more sources

Anticardiolipin antibodies and severe leptospirosis [PDF]

Revista do Instituto de Medicina Tropical de São Paulo, 2003
Laurent RODA
doaj   +5 more sources

Evaluation of Serum Anticardiolipin Antibodies and D-dimer in Recipients of COVID-19 Vaccines in Ado-Ekiti, Ekiti State, Nigeria

Journal of Applied Sciences and Environmental Management, 2023
Coronavirus disease 2019 (COVID-19) manifests itself in a variety of ways, implying a wide range of host autoimmune responses which could lead to disseminated intravascular coagulation.
O. O. Odewusi, J. J. Dodo, F. E. Omotayo, S. O. Obadire, E. A. Omon, M. O. Oguntuase, O. A. Alake   +6 more
doaj   +1 more source

Study on Anticardiolipin Antibodies in Women With Recurrent Abortion in Duhok Province, Kurdistan Region, Iraq

Acta Medica Iranica, 2020
Recurrent abortion is a worldwide issue. Anticardiolipin antibodies (ACA) are found to be among the most important factors related to recurrent spontaneous early pregnancy loss.
Ibrahim A Naqid, Shivan H. Yousif, Amer A Balatay, Djwar Ali Khasho, Nawfal R. Hussein   +4 more
doaj   +1 more source

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

International Journal of Preventive Medicine, 2023
Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour, Mansour Salesi, Fereshteh Keikhaei, Mohammad J. Tarrahi, Zahra Khani, Hassan Salehi   +5 more
doaj   +1 more source

Prevalence of anticardiolipin antibody IgM and IgG in women with recurrent abortions in Kirkuk city

NTU Journal of Pure Sciences, 2023
Toxoplasma gondii, a parasite that can produce a wide range of clinical symptoms in humans, is the source of the zoonotic infection known as Toxoplasmosis.
Muna Aziz, Abeer Ali, Mohammed Hameed
doaj   +1 more source

Antiphospholipid Antibodies in Patients with Type 2 Diabetes Mellitus [PDF]

Annals of the College of Medicine Mosul, 2020
Patients with diabetes mellitus type 2 have a greater risk of accelerated atherosclerosis. Antiphospholipid antibodies(aPL)are associated with greater risk for thrombosis.
Nada Hasso, Ahmed Hussain, Ali Fatheel
doaj   +1 more source

SARS-CoV-2 and Anti-Cardiolipin Antibodies

Clinical Medicine Insights: Case Reports, 2020
The current COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to distinct diagnostic and management challenges for front-line healthcare workers. The risk of excessive coagulation activation leading to a
Mazen Jizzini, Mohsin Shah, Kehua Zhou
doaj   +1 more source

Anticardiolipin antibodies in pathogenesis of infertility [PDF]

Vojnosanitetski Pregled, 2010
Background/Aim. Antiphospholipid syndrome (APS) is an autoimmune disorder clinically characterized by arterial or venous thrombosis and/or specific obstetric complications and presence of antiphospholipid antibodies (aPL) in the serum.
Lončar Dragan
doaj   +1 more source